Clinical Trial Update: Transcatheter Mitral Valve Replacement in Patients With Severe Symptomatic Mitral Regurgitation - APOLLO-EU Trial [NA]

View source ↗

Summary

APOLLO-EU is a recruiting study evaluating transcatheter mitral valve replacement for severe symptomatic mitral regurgitation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Mitral Regurgitation

Drugs mentioned

• Intrepid Transcatheter Mitral Valve System (Transcatheter mitral valve replacement device)

Snippet

Sponsor: Medtronic Cardiovascular | Conditions: Mitral Regurgitation | NA | Status: RECRUITING